171P: Carboplatin–paclitaxel bevacizumab followed by the addition of erlotinib to bevacizumab beyond progression in patients with advanced NSCLC
Van Groningen, H., Timmer-Bonte, A., Hurk, D. Van den, Dohmen, M., Graaf, C. Smits-Van der, Van der Drift, M.Volume:
11
Langue:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/s1556-0864(16)30281-7
Date:
April, 2016
Fichier:
PDF, 66 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
